Projects per year
- 1 - 50 out of 81 results
Search results
-
The Norton-Simon Hypothesis and Tumor-Initiating Cells
Breast Cancer Research Foundation
10/1/10 → 9/30/12
Project: Non Profit
-
Center of Excellence for Individualization of Therapy for Breast Cancer
10/1/10 → 3/31/12
Project: Federal Funding Agencies
-
Developing Effective Therapies for ER-negative Breast Cancer Using Genomics and Proteomics
Univ of Texas MD Anderson Cancer Center
12/8/10 → 7/31/15
Project: Non Profit
-
-
Tageting Notchm P13K-AKT and other novel pathways in breast cancer stem cells
8/1/11 → 7/31/13
Project: Federal Funding Agencies
-
A Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D in premenopausal Women at High Risk for Breast Cancer, Phase IIB
6/29/12 → 3/22/37
Project: Federal Funding Agencies
-
-
Targeting Breast Cancer Tumor Initiating Cells with siRNA
Breast Cancer Research Foundation
10/1/12 → 9/30/16
Project: Non Profit
-
Novel therapeutic approach for targeting triple negative breast cancer stem cells
Chan Soon-Shiong Inst for Adv Health
1/1/13 → 12/31/17
Project: Non Profit
-
Functional analysis and therapeutic potential of miR-708 in triple-negative metastatic breast cancer
9/30/13 → 9/29/16
Project: Federal Funding Agencies
-
Genome sequencing in triple negative breast cancer uncovers response to neoadjuvant chemotherapy
3/5/14 → 9/4/15
Project: Non Profit
-
Stem Cell: Biomarkers Including Putative Stem Cells Markers in Human Breast Cancers
Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Templeton, S.
3/20/14 → …
Project: Clinical Trial
-
Metastatic Stem Cells-ROLE OF CANCER STEM CELLS IN BREAST CANCER RECURRENCE AND METASTASIS
Chang, J. C., Niravath, P. A. & Singh, M.
3/20/14 → …
Project: Clinical Trial
-
A simple assay system for rapid detection of circulating tumor cells.
9/25/14 → 9/24/16
Project: Federal Funding Agencies
-
-
Novel potential drug targets for treatment of triple negative breast cancer
Breast Cancer Research Foundation
10/1/15 → 1/31/20
Project: Non Profit
-
EAY131 - Molecular Analysis for Therapy Choice (MATCH)
Bernicker, E. H., Chang, J. C., Darcourt, J., Heyne, K., Kamat, A. A., Pingali, S. R. & Singh, M.
9/20/16 → 9/20/41
Project: Federal Funding Agencies
-
Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer
Niravath, P. A., Chang, J. C. & Darcourt, J.
9/26/16 → 6/30/18
Project: Federal Funding Agencies
-
NY-ESO-1-specific TCR-engineered T cell immunotherapy for triple negative breast cancer
9/30/16 → 10/28/19
Project: Federal Funding Agencies
-
NY-ESO-1-specific TCR-Engineered T cell Immunotherapy for Triple Negative Breast Cancer
9/30/16 → 9/29/23
Project: Federal Funding Agencies
-
A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Free Fatty Acid Supplementation on Aromatase in Obese Subjects (CTMS# 15-2100)
Niravath, P. A., Chang, J. C. & Darcourt, J.
12/1/16 → 11/30/18
Project: Federal Funding Agencies
-
Identification of novel immune targets and neoantigens for development of immunotherapy for breast cancer
Wang, R., Chang, J. C. & Liu, X.
12/1/16 → 11/30/19
Project: State
-
Targeting the Inflammatory Cancer Stem Cell Microenvironment of Triple Negative Breast Cancer with Leukocyte-mimetic Nanovesicles
Chang, J. C. & Rosato, R. R.
12/1/16 → 11/30/20
Project: State
-
A RANDOMIZED PHASE III DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OFASPIRIN AS ADJUVANT THERAPY FOR HER2 NEGATIVE BREAST CANCER: THE ABCTRIAL
Arentz, C., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
12/8/16 → 12/7/41
Project: Non Profit
-
The inhibitory network between EZH2 and PARP1 in triple-negative breast cancer
Cao, Q., Chang, J. C. & Hu, T.
3/15/17 → 6/30/18
Project: Federal Funding Agencies
-
A Nanodrug for the Cure of Metastatic Breast Cancer
Chang, J. C., Ensor, Jr., J. E. & Liu, X.
7/15/17 → 3/1/20
Project: Federal Funding Agencies
-
Biomimetic nanovesicles to overcome multiple physiological barriers for primary and metastatic triple negative breast cancer therapy
Chang, J. C. & Rosato, R. R.
9/12/17 → 8/31/20
Project: Federal Funding Agencies
-
NRG-BR004: A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Geyer, C. E., Chang, J. C., Darcourt, J. & Niravath, P. A.
3/12/19 → 2/28/25
Project: Non Profit
-
Converting HR+ Breast Cancer Into an Individualized Vaccine
Chang, J. C., Darcourt, J. & Niravath, P. A.
9/30/19 → 9/30/23
Project: Federal Funding Agencies
-
Novel potential drug targets for treatment of triple negative breast cancer
Chang, J. C. & Rosato, R. R.
10/1/19 → 9/30/23
Project: Non Profit
-
Imaging the mechanical microenvironment in cancers using ultrasound
3/1/20 → 2/29/24
Project: Federal Funding Agencies
-
ALLIANCE A221602: OLANZAPINEWITH ORWITHOUT FOSAPREPITANT FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY (HEC): A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Darcourt, J., Bernicker, E. H., Chang, J. C., Geyer, C. E., Heyne, K. & Niravath, P. A.
3/6/20 → 3/5/45
Project: Non Profit
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
Sample and Data Collection for Houston Methodist Cancer Center Research
Chang, J. C., Bernicker, E. H., Darcourt, J., Heyne, K., Niravath, P. A. & Singh, M.
4/9/20 → …
Project: Clinical Trial
-
Convergent AI for Precise Breast Cancer Risk Assessment
Wong, S. T., Chang, J. C. & Ensor, Jr., J. E.
6/1/20 → 5/31/25
Project: Federal Funding Agencies
-
Transforming triple negative breast cancer treatment through intratumoral immunotherapy via nanofluidic drug eluting seed
8/1/20 → 7/31/24
Project: Federal Funding Agencies
-
Targeting the Inflammasome As a Treatment Strategy for COVID-19 infected cancer patients
Chang, J. C. & Rosato, R. R.
8/17/20 → 7/31/22
Project: Federal Funding Agencies
-
Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis
Wong, S. T., Chang, J. C. & Sheng, J.
9/15/20 → 8/31/25
Project: Federal Funding Agencies
-
Contractor shall provide certain breast health screening and diagnostic services
4/1/22 → 4/1/24
Project: Non Profit
-
A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Abdelrahim, M., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
5/2/22 → …
Project: Clinical Trial
-
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
6/10/22 → 5/31/27
Project: Federal Funding Agencies
-
Rationally designed orally delivered small molecules that disable erbB receptors in Breast cancer
10/1/22 → 9/30/23
Project: Federal Funding Agencies
-
Targeting Nitric Oxide Synthase (NOS) pathway to remodel obesity induced tumor inflammation in patients with TNBC
12/1/22 → 11/30/24
Project: State